Exploring metabolic reprogramming in esophageal cancer: the role of key enzymes in glucose, amino acid, and nucleotide pathways and targeted therapies

Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, et al. The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology. 2022;163:649–58.e2.

Article  PubMed  Google Scholar 

Chen R, Zheng R, Zhang S, Wang S, Sun K, Zeng H, et al. Patterns and trends in esophageal cancer incidence and mortality in China: an analysis based on cancer registry data. J Natl Cancer Cent. 2023;3:21–27.

Article  PubMed  PubMed Central  Google Scholar 

Conway E, Wu H, Tian L. Overview of risk factors for esophageal squamous cell carcinoma in China. Cancers. 2023;15:5604.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sheikh M, Roshandel G, McCormack V, Malekzadeh R. Current status and future prospects for esophageal cancer. Cancers. 2023;15:765.

Article  PubMed  PubMed Central  Google Scholar 

Chen L, Zhu S, Liu T, Zhao X, Xiang T, Hu X, et al. Aberrant epithelial cell interaction promotes esophageal squamous-cell carcinoma development and progression. Signal Transduct Target Ther. 2023;8:453.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin D-C, Hao J-J, Nagata Y, Xu L, Shang L, Meng X, et al. Genomic and molecular characterization of esophageal squamous cell carcinoma. Nat Genet. 2014;46:467–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miao P, Sheng S, Sun X, Liu J, Huang G. Lactate dehydrogenase A in cancer: a promising target for diagnosis and therapy. IUBMB Life. 2013;65:904–10.

Article  CAS  PubMed  Google Scholar 

Liberti MV, Locasale JW. The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 2016;41:211–18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu J, Tan M, Cai Q. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. Cancer Lett. 2015;356:156–64.

Article  CAS  PubMed  Google Scholar 

Cai Z, Zhao J-S, Li J-J, Peng D-N, Wang X-Y, Chen T-L, et al. A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism. Mol Cell Proteom. 2010;9:2617–28.

Article  CAS  Google Scholar 

Liu XS, Liu JM, Chen YJ, Li FY, Wu RM, Tan F, et al. Comprehensive analysis of hexokinase 2 immune infiltrates and m6A related genes in human esophageal carcinoma. Front Cell Dev Biol. 2021;9:715883.

Article  PubMed  PubMed Central  Google Scholar 

Bednarz-Misa I, Fortuna P, Fleszar MG, Lewandowski Ł, Diakowska D, Rosińczuk J, et al. Esophageal squamous cell carcinoma is accompanied by local and systemic changes in L-arginine/NO pathway. Nat Clin Pract Gastroenterol Hepatol. 2020;21:6282.

CAS  Google Scholar 

Zhu G, Guan F, Li S, Zhang Q, Zhang X, Qin Y, et al. Glutaminase potentiates the glycolysis in esophageal squamous cell carcinoma by interacting with PDK1. Mol Carcinog. 2024;63:897–911.

Article  CAS  PubMed  Google Scholar 

Yang J, Wang L, Sun H, Zhao Z, Ma Y, Hu Z, et al. Ribonucleotide reductase subunit M1 blocks glucose catabolism via phosphorylation of pyruvate kinase M2 in human esophageal squamous cell cancer. Genes Dis. 2024;11:101000.

Article  CAS  PubMed  Google Scholar 

Qian Y, Liang X, Kong P, Cheng Y, Cui H, Yan T, et al. Elevated DHODH expression promotes cell proliferation via stabilizing β-catenin in esophageal squamous cell carcinoma. Cell Death Dis. 2020;11:862.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui MY, Yi X, Cao ZZ, Zhu DX, Wu J. Targeting strategies for aberrant lipid metabolism reprogramming and the immune microenvironment in esophageal cancer: a review. J Oncol. 2022;2022:4257359.

Article  PubMed  PubMed Central  Google Scholar 

Jiao R, Jiang W, Xu K, Luo Q, Wang L, Zhao C. Lipid metabolism analysis in esophageal cancer and associated drug discovery. J Pharm Anal. 2024;14:1–15.

Article  PubMed  Google Scholar 

de Andrade Barreto E, de Souza Santos PT, Bergmann A, de Oliveira IM, Wernersbach Pinto L, Blanco T, et al. Alterations in glucose metabolism proteins responsible for the Warburg effect in esophageal squamous cell carcinoma. Exp Mol Pathol. 2016;101:66–73.

Article  PubMed  Google Scholar 

Sawayama H, Ishimoto T, Watanabe M, Yoshida N, Baba Y, Sugihara H, et al. High expression of glucose transporter 1 on primary lesions of esophageal squamous cell carcinoma is associated with hematogenous recurrence. Ann Surg Oncol. 2014;21:1756–62.

Article  PubMed  Google Scholar 

Xu S, Wei X. Knockdown of CENPN inhibits glucose metabolism and induces G1 arrest in esophageal cancer cells by regulating PI3K/AKT signaling pathway. Horm Metab Res. 2023;55:563–72.

Article  CAS  PubMed  Google Scholar 

Huang X, Liu C, Li H, Dai T, Luo G, Zhang C, et al. Hypoxia-responsive lncRNA G077640 promotes ESCC tumorigenesis via the H2AX-HIF1α-glycolysis axis. Carcinogenesis. 2023;44:383–93.

Article  CAS  PubMed  Google Scholar 

Lyu SI, Simon AG, Jung JO, Fretter C, SchrÖder W, Bruns CJ, et al. Hexokinase 2 as an independent risk factor for worse patient survival in esophageal adenocarcinoma and as a potential therapeutic target protein: a retrospective, single‑center cohort study. Oncol Lett. 2024;28:495.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garcia SN, Guedes RC, Marques MM. Unlocking the potential of HK2 in cancer metabolism and therapeutics. Curr Med Chem. 2019;26:7285–322.

Article  CAS  PubMed  Google Scholar 

Wang Y, Yu Z, Shi W, Shen J, Guan Y, Ni F. HLA complex P5 upregulation is correlated with poor prognosis and tumor progression in esophageal squamous cell carcinoma. Bioengineered. 2022;13:9301–11.

PubMed  Google Scholar 

Yuan ML, Ren LH, Yu XC, Dong JW, Shi RH. SIRT3 promotes the development of esophageal squamous cell carcinoma by regulating hexokinase 2 through the AKT signaling pathway. Bull Exp Biol Med. 2022;174:81–8.

Article  CAS  PubMed  Google Scholar 

Sun W, Wang D, Zu Y, Deng Y. Long noncoding RNA CASC7 is a novel regulator of glycolysis in oesophageal cancer via a miR-143-3p-mediated HK2 signalling pathway. Cell Death Discov. 2022;8:231.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bao J, Wu Y, Wang L, Zhu Y. The role of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 in esophageal squamous cell carcinoma. Medicine. 2020;99:e19626.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu J, Liu Z-X, Wu Q-N, Lu Y-X, Wong C-W, Miao L, et al. Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming. Nat Commun. 2020;11:1507.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vargas RE, Wang W. Significance of long non-coding RNA AGPG for the metabolism of esophageal cancer. Cancer Commun. 2020;40:313–15.

Article  Google Scholar 

Chang YC, Yang YC, Tien CP, Yang CJ, Hsiao M. Roles of aldolase family genes in human cancers and diseases. Trends Endocrinol Metab. 2018;29:549–59.

Article  CAS  PubMed  Google Scholar 

Tao X, Chen B-l, Yan Y. Correlation between aldolase c (ALDOC) expression and the prognosis of esophageal cancer. Int J Clin Exp Pathol. 2017;10:2036–41.

CAS  Google Scholar 

Jiao J-W, Zhan X-H, Wang J-J, He L-X, Guo Z-C, Xu X-E, et al. LOXL2-dependent deacetylation of aldolase A ind

留言 (0)

沒有登入
gif